(Q41590500)

4 October 2017

1 reference

title

Glucocorticoid medication, memory and steroid psychosis in medical illness (English)

1 reference

4 October 2017

Glucocorticoid Medication, Memory and Steroid Psychosis in Medical Illness (English)

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1997.TB48381.X

15 November 2024

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9292035

15 November 2024

Wolkowitz OM

1 reference

4 October 2017

V. I. Reus

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9292035

15 November 2024

J. Canick

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9292035

15 November 2024

B. Levin

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9292035

15 November 2024

S. Lupien

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9292035

15 November 2024

language of work or name

English

0 references

publication date

1 August 1997

1 reference

4 October 2017

14 August 1997

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9292035

full work available at URL

15 November 2024

number of pages

1 reference

based on heuristic

inferred from page(s)

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1749-6632.1997.tb48381.x

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1997.TB48381.X

https://nyaspubs.onlinelibrary.wiley.com/doi/pdf/10.1111/j.1749-6632.1997.tb48381.x

15 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1997.TB48381.X

Annals of the New York Academy of Sciences

15 November 2024

published in

1 reference

4 October 2017

volume

823

1 reference

4 October 2017

page(s)

81-96

1 reference

Side effects of corticosteroid therapy. Psychiatric aspects.

4 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48381.X

Central nervous system disease in systemic lupus erythematosus. Therapy and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48381.X

Psychic effects of ACTH and cortisone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48381.X

Steroid-induced psychiatric syndromes. A report of 14 cases and a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48381.X

Corticosteroid modulation of hippocampal potentials: increased effect with aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48381.X

The brain as a target for adrenocortical steroids: cognitive implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48381.X

Reversible steroid dementia in patients without steroid psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48381.X

Psychopathological and neuropsychological effects of 8-days' corticosteroid treatment. A prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48381.X

Cognitive effects of corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48381.X

Stress- and treatment-induced elevations of cortisol levels associated with impaired declarative memory in healthy adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48381.X

Steroid modulation of human memory: biochemical correlates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48381.X

Prospective controlled studies of the behavioral and biological effects of exogenous corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48381.X

The Brain as a Target for Steroid Hormone Action

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48381.X

Taste thresholds in man are differentially influenced by hydrocortisone and dexamethasone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48381.X

Relationship between urinary free cortisol and CSF opioid binding activity in depressed patients and normal volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48381.X

Symptomatology and cognitive impairment associate independently with post-dexamethasone cortisol concentrations in unmedicated schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48381.X

Ketoconazole administration in hypercortisolemic depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48381.X

Depressed Mood and Other Psychiatric Manifestations of Cushingʼs Syndrome: Relationship to Hormone Levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48381.X

Long-lasting behavioral changes following prednisone withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48381.X

Psychotic reactions induced by corticotropin (ACTH) cortisone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48381.X

On the various forms of corticosteroid withdrawal syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48381.X

Inverted-U relationship between the level of peripheral corticosterone and the magnitude of hippocampal primed burst potentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48381.X

Cortisol Effects on Averaged Evoked Potential, Alpha-Rhythm, Time Estimation, and Two-Flash Fusion Threshold

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48381.X

Glucocorticoids potentiate ischemic injury to neurons: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48381.X

Exposure to excess glucocorticoids alters dendritic morphology of adult hippocampal pyramidal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48381.X

Hippocampal formation volume, memory dysfunction, and cortisol levels in patients with Cushing's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48381.X

Hypercortisolemia and hippocampal changes in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48381.X

Chronic corticosterone treatment impairs spontaneous alternation behavior in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48381.X

Chlorpromazine prophylaxis of steroid-induced psychosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48381.X

Acute psychosis complicating induction therapy for acute lymphoblastic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48381.X

Is steroid psychosis preventable by divided doses?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48381.X

Alternate-day corticosteroid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48381.X

Differential mood response to natural and synthetic corticosteroids after bilateral adrenalectomy: a case report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48381.X

Presentation of the Steroid Psychoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1997.TB48381.X

Prednisone effects on neurochemistry and behavior. Preliminary findings

15 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1997.TB48381.X

Incidence of serious complications of corticosteroid therapy in respiratory disease: A retrospective survey of patients in the Brompton Hospital

15 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1997.TB48381.X

Comparison of azathioprine, prednisone, and heparin alone or combined in treating lupus nephritis

15 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1997.TB48381.X

Corticosteroids and neuropsychological functioning in patients with systemic lupus erythematosus

15 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1997.TB48381.X

Acute adverse reactions to prednisone in relation to dosage

15 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1997.TB48381.X

Steroid psychosis: a cause of confusion on the acute spinal cord injury unit

15 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1997.TB48381.X

The Influence of Corticosteroids and Theophylline on Cerebral Function

15 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1997.TB48381.X

Commonly used therapeutic doses of glucocorticoids impair explicit memory

15 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1997.TB48381.X

Memory impairment in Cushing's disease.

15 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1997.TB48381.X

Prolonged glucocorticoid exposure reduces hippocampal neuron number: implications for aging

15 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1997.TB48381.X

Aging, stress, and cognitive function

15 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1997.TB48381.X

The glucocorticoid hypothesis of age-related hippocampal neurodegeneration: role of dysregulated intraneuronal calcium.

15 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1997.TB48381.X

Effects of ACTH and prednisone on mood: incidence and time of onset

15 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1997.TB48381.X

Glucocorticoid-induced impairment in declarative memory performance in adult humans

15 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1997.TB48381.X

Cortisol levels and vigilance in eating disorder patients

15 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1997.TB48381.X

Response to steroid suppression in major depression resistant to antidepressant therapy

15 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1997.TB48381.X

Cushing's syndrome after treatment: changes in cortisol and ACTH levels, and amelioration of the depressive syndrome

15 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1997.TB48381.X

Adrenocortical Suppression Presenting with Agitated Depression, Morbid Jealousy, and a Dementia-Like State

15 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1997.TB48381.X

Psychological responses to ACTH and cortisone; a preliminary theoretical formulation

15 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1997.TB48381.X

Preliminary observations on mental disturbances occurring in patients under therapy with cortisone and ACTH.

15 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1997.TB48381.X

Problems of prolonged cortisone treatment for rheumatoid arthritis; further investigations

15 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1997.TB48381.X

Effects of adrenal cortex hormones on limbic structures: some experimental and clinical correlations related to depression

15 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1997.TB48381.X

Quantitative electroencephalographic correlates of steroid administration in man.

15 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1997.TB48381.X

The effects of corticosteroids and ACTH on sensory systems

15 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1997.TB48381.X

Modulation of behavioral inhibition in appetitive extinction following manipulation of adrenal steroids in rats: Implications for involvement of the hippocampus

15 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1997.TB48381.X

The neuroendocrinology of stress and aging: the glucocorticoid cascade hypothesis.

15 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1997.TB48381.X

Hippocampal damage associated with prolonged glucocorticoid exposure in primates

15 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1997.TB48381.X

The physiological relevance of glucocorticoid endangerment of the hippocampus

15 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1997.TB48381.X

Lithium Prophylaxis of Corticotropin-lnduced Psychosis

15 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1997.TB48381.X

Valproate prophylaxis against steroid induced psychosis

15 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1997.TB48381.X

Lithium in steroid-induced depression

15 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1997.TB48381.X

Management of lithium in patients with cancer

15 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1997.TB48381.X

Corticosteroids in cancer: neuropsychiatric complications

15 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1997.TB48381.X

Psychiatric Effects of Alternate Day Steroid Therapy

15 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1997.TB48381.X

Mood effects of alternate-day corticosteroid therapy in patients with systemic lupus erythematosus

15 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1997.TB48381.X

Prednisolone pharmacokinetics and steroid psychosis

15 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1997.TB48381.X

An open study of dehydroepiandrosterone in systemic lupus erythematosus

15 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1997.TB48381.X

Antidepressant and cognition-enhancing effects of DHEA in major depression

15 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1997.TB48381.X

15 November 2024

Identifiers

1 reference

4 October 2017

1 reference